Newsfeeds Archive - Spark Newswire

5 minute read

Why Duolingo Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Thursday’s Mid-Day Session

May 9, 1:57 PM

Shares of Duolingo, Inc. (NASDAQ:DUOL) fell sharply during Thursday’s session after the company reported first quarter financial results.…

ABNB

2 minute read

Movers

12 Health Care Stocks Moving In Thursday’s Pre-Market Session

By Benzinga Insights

May 9, 8:06 AM

Gainers Zai Lab (NASDAQ:ZLAB) stock increased by 21.5% to $20.14 during Thursday’s pre-market session. The market value of…

AADI

1 minute read

Ironwood Pharmaceuticals Lowers 2024 Guidance: Now Expects Sales Between $405M-$425M (Prior $435M-$455M) Vs. 447.9M Consensus; Sees Adjusted EBITDA Above $120M

By Benzinga Newsdesk

May 9, 7:31 AM

Ironwood 2024 Financial Guidance. Ironwood has revised its FY 2024 financial guidance due to a LINZESS gross-to-net change in estimate related to the year ended December 31, 2023. Ironwood now

IRWD

2 minute read

Top 4 Health Care Stocks You May Want To Dump In February

By Avi Kapoor

February 15, 9:15 AM

As of Feb. 15, 2024, four stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

DYN

10 minute read

Earnings

Earnings Scheduled For February 15, 2024

By Benzinga Insights

February 15, 6:17 AM

Companies Reporting Before The Bell • Cognex (NASDAQ:CGNX) is estimated to report quarterly earnings at $0.10 per share on revenue of $188.59 million.

AEM

1 minute read

Earnings

A Preview Of Ironwood Pharmaceuticals’s Earnings

By Benzinga Insights

February 14, 2:02 PM

Ironwood Pharmaceuticals (NASDAQ:IRWD) is set to give its latest quarterly earnings report on Thursday, 2024-02-15. Here’s what investors…

IRWD

3 minute read

Ironwood Announces Publication In The Lancet Gastroenterology & Hepatology Of New Linaclotide Phase III Data In Children And Adolescents Aged 6-17 Years With Functional Constipation

By Benzinga Newsdesk

January 8, 11:59 PM

– Newly published data highlights additional efficacy endpoints from trial –– Linaclotide is the first and only FDA-approved prescription therapy for children and adolescents aged 6-17 years with functional constipation

IRWD

22 minute read

Earnings

Earnings Scheduled For November 9, 2023

By Benzinga Insights

November 9, 7:52 AM

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnings at $0.30 per share on revenue of $265.00 million.

AAOI

1 minute read

News

Ironwood Pharma to Present New Data at NASPGHAN Annual Meeting Reinforcing Impact of Linaclotide on Functional Constipation in Children and Adolescents Ages 6-17 Years-Old

By Benzinga Newsdesk

October 5, 7:34 AM

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD), a leading global gastrointestinal healthcare company, will present findings during the 2023 North American Society for Pediatric Gastroenterology, Hepatology &

IRWD

17 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For September 28, 2023

By Benzinga Insights

September 28, 11:00 AM

Upgrades According to Northcoast Research, the prior rating for Essential Utilities Inc (NYSE:WTRG) was changed from Neutral to…